Victoria Boselli Raposo, Virginia Perdomo, Florencia Pacini, Juan A. Cueto, Alejandro Pezza, Patricia S. Romano, Roberto Docampo, Ana Rosa Perez, Esteban Serra
{"title":"缺乏BDF6严重影响克氏锥虫胞内无尾线虫的发育和传染性","authors":"Victoria Boselli Raposo, Virginia Perdomo, Florencia Pacini, Juan A. Cueto, Alejandro Pezza, Patricia S. Romano, Roberto Docampo, Ana Rosa Perez, Esteban Serra","doi":"10.1021/acsinfecdis.6c00417","DOIUrl":null,"url":null,"abstract":"<p><em>Trypanosoma cruzi</em>, the causative agent\r\nof Chagas\r\ndisease, relies on complex gene regulatory mechanisms to adapt to\r\nits diverse host environments. In recent years, it has been established\r\nthat epigenetics plays an essential role in these mechanisms via the\r\nregulation of chromatin structure. Bromodomain-containing factors\r\n(BDFs), known for recognizing acetylated lysines on histones, have\r\nemerged as key factors in chromatin remodeling complexes. Among the\r\neight predicted BDFs in <em>T. cruzi</em>, BDF6 is part of\r\na TINTIN-like complex with MRGx and MRGBP, homologous to components\r\nof the NuA4/TIP60 chromatin remodeling complex. We generated knockout\r\n(KO) parasites for the <em>bdf6</em> gene using CRISPR/Cas9\r\ngene editing. BDF6 KO epimastigotes exhibit normal morphology but\r\ndecreased size and growth, and the resulting metacyclic trypomastigotes\r\ndisplayed drastically reduced infectivity. Strikingly, once inside\r\nhost cells, KO parasites differentiated into amastigotes but failed\r\nto replicate. This intracellular arrest was reversed by episomal complementation\r\nof BDF6. Consistently, KO parasites also exhibited impaired infectivity\r\nin mice, a defect that was also rescued in the addback parasite lines.\r\nOur findings highlight BDF6 as a critical regulator of intracellular\r\nparasite development, operating in stages beyond epimastigotes where\r\nepigenetic plasticity is essential for host adaptation. This striking\r\nstage-specific phenotype of BDF6 KO underscores its functional importance\r\nand highlights the relevance of epigenetic regulators along <em>T. cruzi</em> life cycle.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 10","pages":"3430–3444"},"PeriodicalIF":4.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"BDF6 Deficiency Severely Compromises Intracellular Amastigote Development and Infectivity of Trypanosoma cruzi\",\"authors\":\"Victoria Boselli Raposo, Virginia Perdomo, Florencia Pacini, Juan A. Cueto, Alejandro Pezza, Patricia S. Romano, Roberto Docampo, Ana Rosa Perez, Esteban Serra\",\"doi\":\"10.1021/acsinfecdis.6c00417\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><em>Trypanosoma cruzi</em>, the causative agent\\r\\nof Chagas\\r\\ndisease, relies on complex gene regulatory mechanisms to adapt to\\r\\nits diverse host environments. In recent years, it has been established\\r\\nthat epigenetics plays an essential role in these mechanisms via the\\r\\nregulation of chromatin structure. Bromodomain-containing factors\\r\\n(BDFs), known for recognizing acetylated lysines on histones, have\\r\\nemerged as key factors in chromatin remodeling complexes. Among the\\r\\neight predicted BDFs in <em>T. cruzi</em>, BDF6 is part of\\r\\na TINTIN-like complex with MRGx and MRGBP, homologous to components\\r\\nof the NuA4/TIP60 chromatin remodeling complex. We generated knockout\\r\\n(KO) parasites for the <em>bdf6</em> gene using CRISPR/Cas9\\r\\ngene editing. BDF6 KO epimastigotes exhibit normal morphology but\\r\\ndecreased size and growth, and the resulting metacyclic trypomastigotes\\r\\ndisplayed drastically reduced infectivity. Strikingly, once inside\\r\\nhost cells, KO parasites differentiated into amastigotes but failed\\r\\nto replicate. This intracellular arrest was reversed by episomal complementation\\r\\nof BDF6. Consistently, KO parasites also exhibited impaired infectivity\\r\\nin mice, a defect that was also rescued in the addback parasite lines.\\r\\nOur findings highlight BDF6 as a critical regulator of intracellular\\r\\nparasite development, operating in stages beyond epimastigotes where\\r\\nepigenetic plasticity is essential for host adaptation. This striking\\r\\nstage-specific phenotype of BDF6 KO underscores its functional importance\\r\\nand highlights the relevance of epigenetic regulators along <em>T. cruzi</em> life cycle.</p>\",\"PeriodicalId\":17,\"journal\":{\"name\":\"ACS Infectious Diseases\",\"volume\":\"12 10\",\"pages\":\"3430–3444\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2026-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00417\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/9/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00417","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
BDF6 Deficiency Severely Compromises Intracellular Amastigote Development and Infectivity of Trypanosoma cruzi
Trypanosoma cruzi, the causative agent
of Chagas
disease, relies on complex gene regulatory mechanisms to adapt to
its diverse host environments. In recent years, it has been established
that epigenetics plays an essential role in these mechanisms via the
regulation of chromatin structure. Bromodomain-containing factors
(BDFs), known for recognizing acetylated lysines on histones, have
emerged as key factors in chromatin remodeling complexes. Among the
eight predicted BDFs in T. cruzi, BDF6 is part of
a TINTIN-like complex with MRGx and MRGBP, homologous to components
of the NuA4/TIP60 chromatin remodeling complex. We generated knockout
(KO) parasites for the bdf6 gene using CRISPR/Cas9
gene editing. BDF6 KO epimastigotes exhibit normal morphology but
decreased size and growth, and the resulting metacyclic trypomastigotes
displayed drastically reduced infectivity. Strikingly, once inside
host cells, KO parasites differentiated into amastigotes but failed
to replicate. This intracellular arrest was reversed by episomal complementation
of BDF6. Consistently, KO parasites also exhibited impaired infectivity
in mice, a defect that was also rescued in the addback parasite lines.
Our findings highlight BDF6 as a critical regulator of intracellular
parasite development, operating in stages beyond epimastigotes where
epigenetic plasticity is essential for host adaptation. This striking
stage-specific phenotype of BDF6 KO underscores its functional importance
and highlights the relevance of epigenetic regulators along T. cruzi life cycle.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.